Euroopan unioni - englanti - EMA (European Medicines Agency)

sandoz gmbh - epoetin alfa - anemia; kidney failure, chronic - antianemic preparations - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients: , treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis;, treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis;, treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre-existing anaemia at the start of chemotherapy).

Euroopan unioni - englanti - EMA (European Medicines Agency)

hexal ag - epoetin alfa - anemia; kidney failure, chronic; cancer - antianemic preparations - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients: , treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis;, treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. , treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre-existing anaemia at the start of chemotherapy).,

Euroopan unioni - englanti - EMA (European Medicines Agency)

pfizer europe ma eeig - epoetin zeta - anemia; blood transfusion, autologous; kidney failure, chronic; cancer - other antianemic preparations - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:treatment of anaemia associated with chronic renal failure in adult and paediatric patients on haemodialysis and adult patients on peritoneal dialysis;treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis.treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre-existing anaemia at the start of chemotherapy).retacrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to patients with moderate anaemia (no iron deficiency), if blood-saving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (four or more units of blood for females or five or more units for males).retacrit can be used to reduce exposure to allogeneic blood transfusions in adult non-iron-deficient patients prior to major elective orthopaedic surgery, having a high perceived risk for transfusion complications. use should be restricted to patients with moderate anaemia (e.g. hb 10-13 g/dl) who do not have an autologous predonation programme available and with expected moderate blood loss (900 to 1800 ml).

Euroopan unioni - englanti - EMA (European Medicines Agency)

stada arzneimittel ag - epoetin zeta - anemia; blood transfusion, autologous; cancer; kidney failure, chronic - antianemic preparations - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patientstreatment of anaemia associated with chronic renal failure in adult and paediatric patients on haemodialysis and adult patients on peritoneal dialysis.treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis.treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre‑existing anaemia at the start of chemotherapy).silapo can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to patients with moderate anaemia (no iron deficiency), if blood saving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males).silapo is indicated for non-iron deficient adults prior to major elective orthopaedic surgery having a high perceived risk for transfusion complications to reduce exposure to allogeneic blood transfusions. use should be restricted to patients with moderate anaemia (e.g. haemoglobin concentration range between 10 to 13 g/dl) who do not have an autologous predonation programme available and with expected moderate blood loss (900 to 1 800 ml).silapo can be used to increase haemoglobin concentration in symptomatic anaemia (haemoglobin concentration of ≤10 g/dl) in adults with low- or intermediate-1-risk primary myelodysplastic syndromes (mds) who have low serum erythropoietin (

Euroopan unioni - englanti - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - patiromer sorbitex calcium - hyperkalemia - drugs for treatment of hyperkalemia and hyperphosphatemia - veltassa is indicated for the treatment of hyperkalaemia in adults.

Euroopan unioni - englanti - EMA (European Medicines Agency)

astrazeneca ab - sodium zirconium cyclosilicate - hyperkalemia - all other therapeutic products - lokelma is indicated for the treatment of hyperkalaemia in adult patients.

Singapore - englanti - HSA (Health Sciences Authority)

emergo singapore consulting private limited - general & plastic surgery - the modular tops™ systems is an alternative to two levels spinal fusion that is designed to stabilize but not fuse the upper affected vertebral level and fuse the lower level; following compression, as a treatment of lower back and leg pain with, or without spinal claudination, that results from moderate or severe lumbar spinal stenosis at two vertebral levels between l3 and s1. patients may also have in addition to lumbar spinal stenosis, degenerative spondylolisthesis (up to grade i) and/or facet arthrosis.

Singapore - englanti - HSA (Health Sciences Authority)

emergo singapore consulting private limited - general & plastic surgery - the tops™ system family is an alternative to spinal fusion that is designed to stabilize but not fuse the affected vertebral level following decompression surgery in the treatment of lower back and leg pain with, or without spinal claudication, that results from moderate or severe lumbar spinal stenosis at one vertebral level between l3 and l5. patients may also have, in addition to lumbar spinal stenosis, degenerative spondylolisthesis (up to grade i) or facet arthrosis. the tops-sp system is indicated for patients between 40 and 75 years of age

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - chicken anaemia virus (living, attenuated) strain 26p4 - misc. vaccines or anti sera - chicken anaemia virus (living, attenuated) strain 26p4 vaccine-viral active 0.0 undefined - immunotherapy - chicken progeny - cav disease

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

the university of melbourne veterinary clinic & hod - calcium carbonate | calcium hydrogen phosphate | magnesium oxide - nutrition & metabolism - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - parturient paresis | hypocalcaemia | milk fever